Concepedia
Statistics
Publications
11
Citations
271
H-Index
10
Active since
2011
Affiliations
Kyushu University(Current)
Saiseikai Fukuoka General Hospital
Cancer Clinic
Japanese Foundation For Cancer Research
Norihiro Koya is an author at Kyushu University specializing in oncology, immunotherapy, and cancer immunotherapy.
Publications per year
2011–2025
Combining celecoxib with sorafenib synergistically inhibits hepatocellular carcinoma cells in vitro.
Takashi Morisaki, Masayo Umebayashi, Akifumi Kiyota et al. · PubMed · 2013 · 51 citations
Medicine, Pharmacology, Pharmacotherapy +14
Combinatorial cytotoxicity of gemcitabine and cytokine-activated killer cells in hepatocellular carcinoma via the NKG2D-MICA/B system.
Takashi Morisaki, Hideya Onishi, Norihiro Koya et al. · PubMed · 2011 · 44 citations
Life Sciences, Immunology, Oncology +16
Combining cetuximab with killer lymphocytes synergistically inhibits human cholangiocarcinoma cells in vitro.
Takashi Morisaki, Masayo Umebayashi, Akifumi Kiyota et al. · PubMed · 2012 · 39 citations
Medicine, Oncology, Pharmacology +17
NKG2D-directed cytokine-activated killer lymphocyte therapy combined with gemcitabine for patients with chemoresistant metastatic solid tumors.
Takashi Morisaki, Tatsuya Hirano, Norihiro Koya et al. · PubMed · 2014 · 35 citations
Life Sciences, Immunology, Oncology +17
Combined Gemcitabine and Metronidazole Is a Promising Therapeutic Strategy for Cancer Stem-like Cholangiocarcinoma
Makoto Kawamoto, Masayo Umebayashi, Hiroto Tanaka et al. · Anticancer Research · 2018 · 21 citations · Full text
1–5 of 11